Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
St. John's Wort for IBS
NCT00587860Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Feb 2006
- Primary completion
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in irritable bowel syndrome (IBS) comparing St. John's Wort with Placebo (2 arms). Primary endpoint: Overall Bowel Symptom Score at 12 weeks. Started Feb 2006; status: completed.
02
Drugs
hypericum perforatum
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT00587860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00587860.